TYROBP and early-onset autosomal dominant Alzheimer disease: TYROBP expression is increased in Alzheimer’s disease (AD) patients, and its deficiency in AD mice showed to be neuroprotective and immune-inflammatory therapeutic, which eventually slowed/arrested the progression of pathological late-onset sporadic AD (Haure-Mirande et al., 2017).